Ingrid N. Moen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 01, 2023
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model.
Journal: Frontiers in medicine
Published: August 31, 2022
TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.
Journal: BMC research notes
Published: June 17, 2022
89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 19, 2021
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.
Journal: Oncotarget
Published: July 30, 2021
Smac-mimetics reduce numbers and viability of human osteoclasts.
Journal: Cell death discovery
Published: December 10, 2020
Development of a novel in situ gelling skin dressing: Delivering high levels of dissolved oxygen at pH 5.5.
Journal: Health science reports
Published: December 15, 2017
Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.
Journal: Clinical & experimental metastasis
Published: June 18, 2014
Last Updated: 09/26/2026